| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | $-0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $-0.41 | $0.52 | $0.32 | $0.24 |
| EPS (Diluted) | $-0.41 | $0.52 | $0.32 | $0.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Total Assets | $13.7B | $14.2B | $15.5B | $16.1B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | — | — | — | — |
| Total Liabilities | $7.9B | $7.6B | $8.6B | $9.1B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | $5.8B | $6.6B | $6.8B | $7.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ |
|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $1.9B | $1.4B | $1.1B |
| Investing Cash Flow | — | — | — | — |
| Capital Expenditures | — | — | — | — |
| Financing Cash Flow | $-0.7B | $-1.8B | $-1.4B | $-1.2B |